BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21252908)

  • 1. F-box protein 10, an NF-κB-dependent anti-apoptotic protein, regulates TRAIL-induced apoptosis through modulating c-Fos/c-FLIP pathway.
    Ge R; Wang Z; Zeng Q; Xu X; Olumi AF
    Cell Death Differ; 2011 Jul; 18(7):1184-95. PubMed ID: 21252908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L).
    Li W; Zhang X; Olumi AF
    Cancer Res; 2007 Mar; 67(5):2247-55. PubMed ID: 17332355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cells.
    Zhang X; Zhang L; Yang H; Huang X; Otu H; Libermann TA; DeWolf WC; Khosravi-Far R; Olumi AF
    Cancer Res; 2007 Oct; 67(19):9425-34. PubMed ID: 17909052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIPL expression.
    Liang DY; Huang W; Chang Q; Hou YQ
    PLoS One; 2018; 13(2):e0191545. PubMed ID: 29444104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.
    Song JH; Kandasamy K; Kraft AS
    J Biol Chem; 2008 Sep; 283(36):25003-13. PubMed ID: 18599488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.
    Zhuang H; Jiang W; Zhang X; Qiu F; Gan Z; Cheng W; Zhang J; Guan S; Tang B; Huang Q; Wu X; Huang X; Jiang W; Hu Q; Lu M; Hua ZC
    J Mol Med (Berl); 2013 Feb; 91(2):219-35. PubMed ID: 22948392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death.
    Thomas RP; Farrow BJ; Kim S; May MJ; Hellmich MR; Evers BM
    Surgery; 2002 Aug; 132(2):127-34. PubMed ID: 12219002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.
    Jani TS; DeVecchio J; Mazumdar T; Agyeman A; Houghton JA
    J Biol Chem; 2010 Jun; 285(25):19162-72. PubMed ID: 20424169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
    Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
    J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.
    Song JH; Tse MC; Bellail A; Phuphanich S; Khuri F; Kneteman NM; Hao C
    Cancer Res; 2007 Jul; 67(14):6946-55. PubMed ID: 17638906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
    Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
    J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner.
    Park EJ; Min KJ; Choi KS; Kwon TK
    Exp Cell Res; 2014 Apr; 323(1):144-154. PubMed ID: 24462458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of FLIP(L) expression and TRAIL resistance by the extracellular signal-regulated kinase1/2 pathway in breast epithelial cells.
    Yerbes R; López-Rivas A; Reginato MJ; Palacios C
    Cell Death Differ; 2012 Dec; 19(12):1908-16. PubMed ID: 22722337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YM155 sensitizes TRAIL-induced apoptosis through cathepsin S-dependent down-regulation of Mcl-1 and NF-κB-mediated down-regulation of c-FLIP expression in human renal carcinoma Caki cells.
    Woo SM; Min KJ; Seo BR; Kwon TK
    Oncotarget; 2016 Sep; 7(38):61520-61532. PubMed ID: 27528031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids.
    Yang TM; Barbone D; Fennell DA; Broaddus VC
    Am J Respir Cell Mol Biol; 2009 Jul; 41(1):14-23. PubMed ID: 19097992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
    Zhang JS; Herreros-Villanueva M; Koenig A; Deng Z; de Narvajas AA; Gomez TS; Meng X; Bujanda L; Ellenrieder V; Li XK; Kaufmann SH; Billadeau DD
    Cell Death Dis; 2014 Mar; 5(3):e1142. PubMed ID: 24675460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
    Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
    Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.
    Jane EP; Premkumar DR; Pollack IF
    Mol Cancer Ther; 2011 Jan; 10(1):198-208. PubMed ID: 21220502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.
    Travert M; Ame-Thomas P; Pangault C; Morizot A; Micheau O; Semana G; Lamy T; Fest T; Tarte K; Guillaudeux T
    J Immunol; 2008 Jul; 181(2):1001-11. PubMed ID: 18606651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the resistance to TRAIL-induced apoptosis in human primary T lymphocytes: role of NF-kappaB inhibition.
    Morales JC; Ruiz-Magaña MJ; Ruiz-Ruiz C
    Mol Immunol; 2007 Apr; 44(10):2587-97. PubMed ID: 17257681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.